Trinity Biotech director files Form 3 insider report

Trinity Biotech plc director John Paul Tivnan has filed a Form 3 insider ownership report for ticker TRIB.

Rhea-AI Filing Summary

Trinity Biotech plc director John Paul Tivnan has filed a Form 3 insider ownership report for ticker TRIB. The data provided show no reported transactions, with buy, sell, exercise, gift, tax withholding, and restructuring share counts all at zero, indicating purely a baseline regulatory filing.

Key Terms

reportingPersons, transactionSummary, derivativeSummary

3 terms

reportingPersons financial

""reportingPersons": [ { "name": "Tivnan John Paul""

transactionSummary financial

""transactionSummary": { "buyCount": 0, "sellCount": 0"

derivativeSummary financial

""derivativeSummary": []"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the John Paul Tivnan Form 3 filing for TRIB show?

The Form 3 for TRINITY BIOTECH PLC (TRIB) records John Paul Tivnan as a director and shows no insider trading activity. All transaction counts and share amounts, including buys, sells, exercises, gifts, and tax withholdings, are listed as zero in the transaction summary.

Does the TRIB Form 3 for John Paul Tivnan report any share purchases or sales?

No. The Form 3 transaction summary for John Paul Tivnan at TRINITY BIOTECH PLC shows zero buy shares, zero sell shares, and a neutral net buy/sell direction. This indicates there were no reported purchases, sales, or option exercises in this filing’s data.

What roles does John Paul Tivnan hold at TRINITY BIOTECH PLC (TRIB)?

John Paul Tivnan is identified as a director of TRINITY BIOTECH PLC in the Form 3 data. The filing flags him as a director, not as an officer or ten-percent owner, meaning his insider status here is based on his board position.

Are there any derivative securities reported for John Paul Tivnan in this TRIB Form 3?

No derivative securities are listed in the Form 3 data for John Paul Tivnan at TRINITY BIOTECH PLC. The derivative summary is empty and the derivative transaction count in the transaction summary is zero, indicating no options, warrants, or similar instruments are reported here.

What does a neutral net buy/sell direction mean in the TRIB Form 3 summary?

The Form 3 transaction summary for John Paul Tivnan at TRINITY BIOTECH PLC shows a neutral net buy/sell direction with netBuySellShares equal to zero. This reflects that no insider buying or selling activity is reported in the data for this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 08:14 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tivnan John Paul

(Last) (First) (Middle)

TRINITY BIOTECH PLC

IDA BUSINESS PARK, WICKLOW

(Street)

BRAY A98 H5C8

(City) (State) (Zip)

IRELAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TRINITY BIOTECH PLC [ TRIB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ John Paul Tivnan	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)